Level Biotechnology (3118) — Capital Reinvestment Ratio
Latest as of September 2025:
0.38x
Level Biotechnology (3118) has a Capital Reinvestment Ratio of 0.38x as of September 2025, meaning it reinvests 0% of its operating cash flow (NT$11.81 Million) in capital expenditures (NT$4.44 Million). See Level Biotechnology (3118) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.38x
Capex / Operating Cash Flow
Operating Cash Flow
NT$11.81 Million
TWD
Capital Expenditures
NT$4.44 Million
TWD
Data as of
Sep 2025
Most recent filing
Level Biotechnology Capital Reinvestment Ratio (2017–2024)
This chart tracks Level Biotechnology's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Level Biotechnology (2017–2024)
Year-by-year Capital Reinvestment Ratio for Level Biotechnology from 2017 to 2024. For live market cap and broader valuation context, see market value of Level Biotechnology.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 3.49x | NT$64.10 Million | NT$223.68 Million | ▲ +3095.2% |
| 2023 | 0.11x | NT$70.21 Million | NT$7.67 Million | ▲ +5.5% |
| 2022 | 0.10x | NT$65.07 Million | NT$6.74 Million | ▲ +76.4% |
| 2021 | 0.06x | NT$155.95 Million | NT$9.15 Million | ▲ +92.3% |
| 2020 | 0.03x | NT$83.23 Million | NT$2.54 Million | ▲ +37.2% |
| 2019 | 0.02x | NT$109.02 Million | NT$2.43 Million | ▼ -76.3% |
| 2018 | 0.09x | NT$26.77 Million | NT$2.51 Million | ▼ -38.2% |
| 2017 | 0.15x | NT$71.29 Million | NT$10.83 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow